findmyKOL
Clinical trialNCT06252402RecruitingEarly phase 1Interventional

CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS

SponsorCity of Hope Medical CenterEnrollment15HIV-1
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Medical Center

    Duarte, California, United States

    John H. Baird, MD
    Recruiting
  • Ucsd, Division of Infectious Diseases and Global Public Health

    San Diego, California, United States

    David Smith, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Dec 2024
Primary completion
11 Dec 2026
Completion
11 Dec 2026
Last update posted
23 Feb 2026
Registered enrollment
15
Registry id
NCT06252402

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.